McMaster Textbook of Internal Medicine
Interviews
VTE
Differences in risk stratification, prophylaxis, and treatment of thrombosis in patients with cancer...

Differences in risk stratification, prophylaxis, and treatment of thrombosis in patients with cancer vs patients with nonneoplastic diseases

2015-06-05

Mark Crowther

See also

Management of patients with a history of GI bleeding who require anticoagulant treatment because of a high CHA₂DS₂-VASc score How should we manage patients with a history of gastrointestinal bleeding who require anticoagulant treatment because of a high CHA₂DS₂-VASc score? Should we prefer novel oral anticoagulants in such patients?
Evidence suggesting benefits of D-dimer monitoring in patients with cancer or chronic diseases Is there any evidence suggesting benefits of D-dimer monitoring in patients with cancer or chronic diseases? As we know that chronic diseases cause elevation in D-dimer levels, should we still measure this parameter to exclude thrombosis?

We would love to hear from you

Comments, mistakes, suggestions?